Related Experiment Videos
Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation.
1Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.
Oncogene
|May 24, 2000
Summary
E2F1 transcription factor expression significantly inhibits NIH3T3 cell growth and transformation. However, some cells with specific alterations can overcome this E2F1-mediated growth inhibition.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The E2F family of transcription factors plays a crucial role in cell cycle regulation.
- Upregulation of E2F has been linked to neoplastic phenotypes, but its role as a tumor suppressor is under investigation.
Purpose of the Study:
- To investigate the tumor suppressor properties of E2F1.
- To determine the effect of exogenous E2F expression on cell growth and transformation in NIH3T3 cells.
Main Methods:
- Utilized a tissue culture model system (NIH3T3 cells).
- Assessed colony formation and focus formation assays.
- Investigated the role of E2F DNA binding activity and protein interaction domains.
Main Results:
- Exogenous E2F expression led to an 80% decrease in NIH3T3 colony formation and inhibited Ras-mediated focus formation.
- E2F's inhibitory effect was dependent on DNA binding but not specific protein domains.
- Exogenous E2F also inhibited the growth of pre-transformed NIH3T3 cells (Ras or Neu).
- Early transfection resulted in significant cell population loss, with a subset of cells eventually unaffected.
Conclusions:
- E2F1 exhibits tumor suppressor properties by inhibiting cell growth and transformation.
- Cells that acquire dominant alterations can evade E2F-mediated growth inhibition.
- Increased E2F activity may only be tolerated in cells with specific, dominant genetic changes.